The pivotal outcomes of the RIVER Trial, which stands for Rivaroxaban for Valvular Heart Disease and Atrial Fibrillation, have unveiled that rivaroxaban stands on par with warfarin in terms of effectiveness and impact.
Read More
Alzheimer's disease stands as the leading cause of dementia. In recent times, scientific inquiry has turned towards the potential involvement of gut microbiota in the disease's development.
Read More
Shedding a few kilograms in weight can significantly reduce the risk of Type 2 diabetes, as demonstrated by an extensive research study led by the Norfolk and Norwich University Hospital and the University of East Anglia.
Read More
Recent research unveils a promising breakthrough: a straightforward skin test can effectively detect Parkinson's disease, potentially enabling earlier diagnosis and improved patient outcomes. Presently, clinical signs and symptoms guide diagnosis, with confirmation post-mortem.
Read More
The hallmark of various diseases, including Alzheimer's, Parkinson's, and type 2 diabetes, are pathological protein clumps. Using cryo-electron microscopy, scientists have achieved a groundbreaking view of protein string arrangements within diabetes-associated deposits.
Read More
The FDA's recent approval of diazepam nasal spray (Valtoco, Neurelis) signifies a breakthrough for epilepsy patients aged 6 and older, offering acute treatment for distinct seizure episodes, including clusters.
Read More
Parkinson's disease is known for motor symptoms like tremors and slow movement, yet its causes remain unclear. Recent research challenges prevailing notions, potentially shedding light on crucial Parkinson's mechanisms.
Read More
Raynaud's Phenomenon often overlaps with lupus. This blog delves into the condition, its signs, and effective management strategies.
Read More
Craft your ultimate gluten-free Thanksgiving meal using our comprehensive Celiac Thanksgiving Guide for a delicious and safe feast.
Read More